Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells


Study Number
439919
Phase
N/A
Age Group
Adult
Purpose

This is a prospective study for the long-term follow-up (LTFU) of safety and efficacy for all pediatric and adult participants exposed to Gene-modified (GM) T cell therapy participating in a previous Celgene sponsored or Celgene alliance partner sponsored study. Participants who received at least one GM T cell infusion will be asked to enroll in this LTFU protocol upon either premature discontinuation from, or completion of the prior parent treatment protocol.

Full Title

Long-Term Follow-Up Protocol for Subjects Treated with Gene-Modified T Cells

ClinicalTrials.Gov ID
NCT03435796

To inquire about participating in these studies, call 1-800-ROSWELL (1-800-767-9355) or e-mail askroswell@roswellpark.org.